000148979 001__ 148979 000148979 005__ 20250130163248.0 000148979 0247_ $$2doi$$a10.1016/j.carrev.2023.01.027 000148979 0248_ $$2sideral$$a142093 000148979 037__ $$aART-2023-142093 000148979 041__ $$aeng 000148979 100__ $$aRodriguez-Leor, Oriol 000148979 245__ $$aChanges in the treatment strategy following intracoronary pressure wire in a contemporaneous real-life cohort of patients with intermediate coronary stenosis. results from a nationwide registry 000148979 260__ $$c2023 000148979 5203_ $$aBackground Intracoronary pressure wire is useful to guide revascularization in patients with coronary artery disease. Aims To evaluate changes in diagnosis (coronary artery disease extent), treatment strategy and clinical results after intracoronary pressure wire study in real-life patients with intermediate coronary artery stenosis. Methods Observational, prospective and multicenter registry of patients in whom pressure wire was performed. The extent of coronary artery disease and the treatment strategy based on clinical and angiographic criteria were recorded before and after intracoronary pressure wire guidance. 12-month incidence of MACE (cardiovascular death, non-fatal myocardial infarction or new revascularization of the target lesion) was assessed. Results 1414 patients with 1781 lesions were included. Complications related to the procedure were reported in 42 patients (3.0 %). The extent of coronary artery disease changed in 771 patients (54.5 %). There was a change in treatment strategy in 779 patients (55.1 %) (18.0 % if medical treatment; 68.8 % if PCI; 58.9 % if surgery (p < 0.001 for PCI vs medical treatment; p = 0.041 for PCI vs CABG; p < 0.001 for medical treatment vs CABG)). In patients with PCI as the initial strategy, the change in strategy was associated with a lower rate of MACE (4.6 % vs 8.2 %, p = 0.034). Conclusions The use of intracoronary pressure wire was safe and led to the reclassification of the extent of coronary disease and change in the treatment strategy in more than half of the cases, especially in patients with PCI as initial treatment. 000148979 540__ $$9info:eu-repo/semantics/closedAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/ 000148979 592__ $$a0.493$$b2023 000148979 593__ $$aMedicine (miscellaneous)$$c2023$$dQ3 000148979 593__ $$aCardiology and Cardiovascular Medicine$$c2023$$dQ3 000148979 594__ $$a3.3$$b2023 000148979 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000148979 700__ $$aToledano, Beatriz 000148979 700__ $$aLópez-Palop, Ramón 000148979 700__ $$aRivero, Fernando 000148979 700__ $$aBrugaletta, Salvatore 000148979 700__ $$0(orcid)0000-0002-4236-6954$$aLinares, José Antonio$$uUniversidad de Zaragoza 000148979 700__ $$aBenito, Tomás 000148979 700__ $$aCarrillo, Pilar 000148979 700__ $$aPuigfel, Martí 000148979 700__ $$aCediel, German 000148979 700__ $$aSadaba, Mario 000148979 700__ $$aVaquerizo, Beatriz 000148979 700__ $$aRondán, Juan 000148979 700__ $$aGómez, Iván 000148979 700__ $$aAlfonso, Fernando 000148979 700__ $$aSáez, Roberto 000148979 700__ $$aPlanas, Ana 000148979 700__ $$aLozano, Fernando 000148979 700__ $$aHernández, Felipe 000148979 700__ $$aSabaté, Manel 000148979 700__ $$aRuíz-Arroyo, José Ramón 000148979 700__ $$aTorres, Francisco 000148979 700__ $$ade la Torre Hernández, José María 000148979 700__ $$aGutiérrez, Enrique 000148979 700__ $$aCid-Álvarez, Ana Belén 000148979 700__ $$aDíez, José Luís 000148979 700__ $$aFernández, Luis 000148979 700__ $$aMoreu, José 000148979 700__ $$aOjeda, Soledad 000148979 700__ $$aCerrato, Pablo 000148979 700__ $$aRuiz-Quevedo, Valeriano 000148979 700__ $$aSanchis, Juan 000148979 700__ $$aGómez-Menchero, Antonio 000148979 700__ $$aOcaranza, Raymundo 000148979 700__ $$aMohandes, Mohsen 000148979 700__ $$aHernández, José María 000148979 700__ $$aAlfageme, Miren Maite 000148979 700__ $$aAguiar, Pablo 000148979 700__ $$aLópez Mínguez, José Ramón 000148979 700__ $$aPérez de Prado, Armando 000148979 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina 000148979 773__ $$g51 (2023), 55-64$$pCardiovasc. revasc. med.$$tCardiovascular revascularization medicine$$x1553-8389 000148979 8564_ $$s1495330$$uhttps://zaguan.unizar.es/record/148979/files/texto_completo.pdf$$yVersión publicada 000148979 8564_ $$s2405428$$uhttps://zaguan.unizar.es/record/148979/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000148979 909CO $$ooai:zaguan.unizar.es:148979$$particulos$$pdriver 000148979 951__ $$a2025-01-30-16:31:29 000148979 980__ $$aARTICLE